Study Title: Trauma Exposure Among Individuals in Medication Treatment for Opioid Use Disorder
Background
Little is known about the lifetime trauma exposure of individuals in medication treatment for opioid use disorder (MOUD). A recent study examined the prevalence of lifetime trauma and differences based on gender, PTSD status, and chronic pain.
Methods
A cross-sectional study analyzed baseline data from 303 participants enrolled in a randomized controlled trial of a mind-body intervention as an adjunct to MOUD. Measures included the Trauma Life Events Questionnaire (TLEQ), the Brief Pain Inventory (BPI), and the Posttraumatic Stress Disorder Checklist (PCL-5).
Results
Findings revealed a high prevalence of lifetime trauma among individuals in MOUD, with significant differences in trauma exposure by gender, PTSD status, and chronic pain. Women reported more intimate partner violence and adult sexual assault, while men reported more physical assault and witnessing trauma. Participants with chronic pain had significantly more traumatic events in childhood compared to those without chronic pain.
Conclusion
The study underscores the need for comprehensive assessment and mental health services to address trauma among individuals in MOUD treatment.
Trial Registration
NCT04082637
Practical Solutions and Value
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians. Additionally, our mobile apps support scheduling, monitoring treatments, and telemedicine, streamlining operations and improving patient outcomes. Learn more about how we can help at aidevmd.com.
